Published in Q J Med on October 01, 1978
CT abnormalities of the pituitary in hyperprolactinaemic women with normal or equivocal sellae radiologically. Br Med J (Clin Res Ed) (1982) 1.02
Treatment of presumed prolactinoma by transsphenoidal operation: early and late results. Br Med J (Clin Res Ed) (1985) 0.89
Effect of radiation on the human reproductive system. Environ Health Perspect (1993) 0.89
Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev (2012) 0.82
Combined use of vasopressin and synthetic hypothalamic releasing factors as a new test of anterior pituitary function. Br Med J (Clin Res Ed) (1986) 0.81
Dopamine in the pituitary adaptation to starvation in man. Postgrad Med J (1985) 0.75
Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ (2001) 2.91
Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37
Pituitary ablation for diabetic retinopathy. Q J Med (1965) 2.34
Imaging of the brain by nuclear magnetic resonance. Lancet (1981) 2.19
Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. Br J Clin Pharmacol (1978) 2.14
Diabetic retinopathy. I. The assessment of severity and progress by comparison with a set of standard fundus photographs. Diabetologia (1967) 1.93
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Interactions between herpes simplex virus DNA-binding proteins. J Gen Virol (1984) 1.89
Vitamin-D deficiency and primary hyperparathyroidism. Lancet (1971) 1.71
Calcitonin for prevention of postmenopausal bone loss. Lancet (1988) 1.71
Effect of thyrocalcitonin in man. Lancet (1966) 1.67
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Initial clinical evaluation of a whole body nuclear magnetic resonance (NMR) tomograph. J Comput Assist Tomogr (1982) 1.63
Calcium metabolism and bone pathology in adult coeliac disease. Q J Med (1970) 1.63
An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol (1967) 1.62
Effects of cholera and E. coli enterotoxins on cyclic adenosine 3',5'-monophosphate levels and intermediary metabolism in the thyroid. Endocrinology (1973) 1.59
Phosphate treatment of hypercalcaemia due to carcinoma. Br Med J (1968) 1.54
Modified method of spinal computed tomography for trabecular bone mineral measurements. J Comput Assist Tomogr (1986) 1.53
The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med (1982) 1.49
Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation. Diabetes (1976) 1.48
Parathyroid hormone and experimental osteosclerosis. Lancet (1970) 1.42
Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clin Endocrinol (Oxf) (1998) 1.40
Cushing's disease. Treatment by pituitary implantation of radioactive gold or yttrium seeds. Q J Med (1973) 1.39
Therapeutic success in severe iatrogenic osteoporosis in a young woman. J R Soc Med (1993) 1.37
Chemistry, physiology, and therapeutic applications of calcitonin. Arthritis Rheum (1980) 1.34
The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone (2004) 1.30
Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol (1993) 1.28
Radiological evidence of a dose-related response to long-term treatment of Paget's disease with human calcitonin. Br J Radiol (1974) 1.26
Baculovirus expression of the human papillomavirus type 16 capsid proteins: detection of L1-L2 protein complexes. J Gen Virol (1991) 1.24
Abnormal calcium metabolism in normocalcaemic sarcoidosis. Br Med J (1976) 1.22
Effect of thyrocalcitonin on bone. Lancet (1966) 1.21
Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs. Endocrinology (1975) 1.20
Detection of low bone mineral density by dual energy x ray absorptiometry in unsuspected suboptimally treated coeliac disease. Gut (1995) 1.20
The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet (1999) 1.19
Triton X-100 scintillant for counting calcium-45 in biological fluids. Int J Appl Radiat Isot (1969) 1.16
Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Arterioscler Thromb Vasc Biol (1998) 1.14
Healing of the bones in juvenile Paget's disease treated by human calcitonin. Br J Radiol (1974) 1.14
Studies on the herpes simplex virus alkaline nuclease: detection of type-common and type-specific epitopes on the enzyme. J Gen Virol (1985) 1.14
Changed levels of endogenous sex steroids in women on oral contraceptives. Br Med J (1976) 1.14
Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer. J Urol (2004) 1.12
Pituitary tumour treated by pituitary implantation of yttrium 90 during or before pregnancy (two cases). Proc R Soc Med (1972) 1.12
Effects of methyldopa on prolactin and growth hormone. Br Med J (1976) 1.11
Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab (2001) 1.10
Long term treatment of acromegaly with a long acting analogue of somatostatin. Br Med J (Clin Res Ed) (1985) 1.09
Failure of corticosteroid therapy to correct the hypercalcaemia of malignant disease. Lancet (1970) 1.08
Pregnancies in women with hyperprolactinaemia: clinical course and obstetric complications of 41 pregnancies in 27 women. Br J Obstet Gynaecol (1979) 1.08
Letter: Bromocritine and serum-growth-hormone levels in diabetes mellitus. Lancet (1975) 1.07
Prolactin studies in "functionless" pituitary tumours. Br Med J (1975) 1.07
Therapeutic adrenal venous infarction in ACTH-dependent Cushing's syndrome. Br J Radiol (1981) 1.06
Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995). Clin Endocrinol (Oxf) (1987) 1.06
Diabetic retinopathy. II. Comparison of disease remission induced by various degrees of pituitary ablation by Y90. Diabetologia (1967) 1.06
Acromegaly and narcolepsy. Lancet (1979) 1.05
Radiological patterns of bone disease associated with renal glomerular failure in adults. Br Med Bull (1972) 1.05
Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes. Diabetologia (1982) 1.04
Some acute effects of administered porcine calcitonin in man. Clin Sci (1969) 1.03
An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings. Q J Med (1990) 1.03
Equations for the prediction of normal values for exchangeable sodium, exchangeable potassium, extracellular fluid volume, and total body water. Br Med J (1973) 1.03
The relationships between cardiovascular risk factors and socio-economic status in people with diabetes. Diabet Med (1996) 1.02
Radiological regression in Paget's disease treated by human calcitonin. Lancet (1972) 1.02
CT abnormalities of the pituitary in hyperprolactinaemic women with normal or equivocal sellae radiologically. Br Med J (Clin Res Ed) (1982) 1.02
Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients. Q J Med (1983) 1.02
Estimation of pituitary gland dimensions from radiographs of the sella turcica. A post-mortem study. Br J Radiol (1968) 1.01
Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab (2000) 0.99
Urinary excretion of phosphate in normal children. Arch Dis Child (1970) 0.98
Paget's disease in a 5-year-old: acute response to human calcitonin. Br Med J (1972) 0.98
Prostatic cancer: treatment with long-acting LHRH analogue. Br J Urol (1983) 0.98
Retinal pigment epithelial change and partial lipodystrophy. Postgrad Med J (1988) 0.98
The use of yttrium 90 implantation in the treatment of acromegaly. Proc R Soc Med (1970) 0.98
The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. Clin Radiol (1972) 0.98
Nuclear magnetic resonance imaging of the liver: initial experience. AJR Am J Roentgenol (1982) 0.98
Virilism with Hilus Cell Hyperplasia. Proc R Soc Med (1962) 0.97
Serum growth hormone levels and size of pituitary tumour in untreated acromegaly. Br Med J (1969) 0.97
Normocalcaemic hyperparathyroidism. Proc R Soc Med (1968) 0.97
Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab (2000) 0.97
An ovarian lipid cell tumour causing virilization and Cushing's syndrome. Clin Endocrinol (Oxf) (1996) 0.97
Hepatitis C virus seroprevalence in clients of sexually transmitted disease clinics in North Carolina. Sex Transm Dis (1994) 0.97
Osteoporosis and calcitonin deficiency. Br Med J (Clin Res Ed) (1982) 0.96
Hypothalamic-pituitary function in the "brain-dead" patient. Lancet (1980) 0.96
The effect of yttrium-90 implantation on endocrine function and visual fields in patients with "functionless" pituitary tumors, with biopsy and radiological findings. Clin Endocrinol (Oxf) (1975) 0.96
Magnetic resonance properties of hydrogen: imaging the posterior fossa. AJR Am J Roentgenol (1981) 0.96
Some quantitative radiological observations in primary and secondary hyperparathyroidism. Br J Radiol (1966) 0.95
Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcif Tissue Int (1996) 0.95